Cargando…
Expanding the Utilization of Rectal Spacer Hydrogel for Larger Prostate Glands (>80 cc): Feasibility and Dosimetric Outcomes
PURPOSE: The Hydrogel Spacer Prospective Randomized Pivotal Trial achieved mean rectoprostatic spacing of 12.6 mm resulting in lowering of rectal V70 from 12.4% (without spacer) to 3.3% (with spacer) in patients with glands up to 80 cm(3). The value of this approach in patients with larger glands is...
Autores principales: | Fagundes, Marcio, Rodrigues, Maria Amelia, Olszewski, Steve, Khan, Fazal, McKenzie, Craig, Gutierrez, Alonso, Chuong, Michael, Mehta, Minesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233470/ https://www.ncbi.nlm.nih.gov/pubmed/34195489 http://dx.doi.org/10.1016/j.adro.2021.100651 |
Ejemplares similares
-
Rectal dose to prostate cancer patients treated with proton therapy with or without rectal spacer
por: Chung, Heeteak, et al.
Publicado: (2016) -
Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy
por: Vanneste, Ben G.L., et al.
Publicado: (2018) -
Safety and effectiveness of high-power thulium laser enucleation of the prostate in patients with glands larger than 80 mL
por: Chang, Ching-Hsin, et al.
Publicado: (2019) -
Rectal dose-sparing effect with bioabsorbable spacer placement in carbon ion radiotherapy for sacral chordoma: dosimetric comparison of a simulation study
por: Shiba, Shintaro, et al.
Publicado: (2021) -
Dosimetric Advantages of Silicone-Filled Vaginal Spacers in Pediatric Proton Therapy
por: Ates, Ozgur, et al.
Publicado: (2022)